114 related articles for article (PubMed ID: 29290173)
1. Comparison of Specialty Medication Use for Common Chronic Inflammatory Diseases Among Health Exchange and Other Commercially Insured Members.
Chen X; Gautam S; Ruggieri A; Richards T; Devries A; Sylwestrzak G
J Manag Care Spec Pharm; 2018 Jan; 24(1):12-19. PubMed ID: 29290173
[TBL] [Abstract][Full Text] [Related]
2. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
3. Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage Population.
Chung H; Deshpande G; Zolotarjova J; Quimbo RA; Kern DM; Cochetti PT; Willey VJ
J Manag Care Spec Pharm; 2019 May; 25(5):612-620. PubMed ID: 31039058
[TBL] [Abstract][Full Text] [Related]
4. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
[TBL] [Abstract][Full Text] [Related]
5. An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.
Robinson SW; Brantley K; Liow C; Teagarden JR
J Manag Care Spec Pharm; 2014 Oct; 20(10):997-1004. PubMed ID: 25278322
[TBL] [Abstract][Full Text] [Related]
6. Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits.
Smith JJ; Qiu Y; Lam SV; Lockwood CM; Pegus C; Gleason PP
J Manag Care Spec Pharm; 2020 Jun; 26(6):766-774. PubMed ID: 32154745
[TBL] [Abstract][Full Text] [Related]
7. Use of Prescription Assistance Programs After the Affordable Health Care Act.
Khan G; Karabon P; Lerchenfeldt S
J Manag Care Spec Pharm; 2018 Mar; 24(3):247-251. PubMed ID: 29485949
[TBL] [Abstract][Full Text] [Related]
8. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
Yeung K; Barthold D; Dusetzina SB; Basu A
N Engl J Med; 2020 Aug; 383(6):558-566. PubMed ID: 32757524
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access Restriction.
Chen CC; De AP; Sweet B; Wade RL
J Manag Care Spec Pharm; 2017 Aug; 23(8):902-912. PubMed ID: 28737985
[TBL] [Abstract][Full Text] [Related]
10. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
[TBL] [Abstract][Full Text] [Related]
11. Lowering Cost Share May Improve Rates of Home Glucose Monitoring Among Patients with Diabetes Using Insulin.
Xie Y; Agiro A; Bowman K; DeVries A
J Manag Care Spec Pharm; 2017 Aug; 23(8):884-891. PubMed ID: 28737991
[TBL] [Abstract][Full Text] [Related]
12. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation.
Adeboyeje G; Sylwestrzak G; Barron JJ; White J; Rosenberg A; Abarca J; Crawford G; Redberg R
J Manag Care Spec Pharm; 2017 Sep; 23(9):968-978. PubMed ID: 28854073
[TBL] [Abstract][Full Text] [Related]
13. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
14. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users.
Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A
J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820
[TBL] [Abstract][Full Text] [Related]
15. Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study.
Khilfeh I; Guyette E; Watkins J; Danielson D; Gross D; Yeung K
J Manag Care Spec Pharm; 2019 Apr; 25(4):461-467. PubMed ID: 30917076
[TBL] [Abstract][Full Text] [Related]
16. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
17. Plan Selection, Enrollee Risk, and Health Spending on the Patient Protection and Affordable Care Act Individual Marketplaces, 2019.
Treasure G; Anderson DM; Hatcher L; Makhoul AE; Johnson D; Stefan J; Griffith KN
JAMA Netw Open; 2023 Mar; 6(3):e234529. PubMed ID: 36995715
[TBL] [Abstract][Full Text] [Related]
18. Changes in Consumer Cost-Sharing for Health Plans Sold in the ACA's Insurance Marketplaces, 2015 to 2016.
Gabel J; Green M; Call A; Whitmore H; Stromberg S; Oran R
Issue Brief (Commonw Fund); 2016 May; 11():1-14. PubMed ID: 27214926
[TBL] [Abstract][Full Text] [Related]
19. Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.
Després F; Forget A; Kettani FZ; Blais L
J Manag Care Spec Pharm; 2016 May; 22(5):539-47. PubMed ID: 27123915
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
Kale HP; Patel AM; Carroll NV
J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
